⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11450880 | 0.81 | NOS1 (0.33) | — | |
| SCHEMBL6600699 | 0.76 | NOS1 (0.33) | — | |
| SCHEMBL16373416 | 0.74 | — | — | |
| SCHEMBL13877116 | 0.73 | — | — | |
| SCHEMBL4077363 | 0.72 | — | — | |
| SCHEMBL4077365 | 0.72 | — | — | |
| SCHEMBL5679697 | 0.69 | — | — | |
| SCHEMBL10743401 | 0.68 | HPGD (0.41) | — | |
| SCHEMBL10743394 | 0.68 | HPGD (0.41) | — | |
| SCHEMBL20104771 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991013616-A1 | NOVEL HMG-CoA REDUCTASE INHIBITORS | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1991-09-19 | — | — | WO | disclosed |
| US-4996234-A | Anticholesterol agents | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-02-26 | — | — | US | disclosed |
| US-4900754-A | ANTICHOLESTEROL AGENTS | RORER PHARMACEUTICAL CORP. (US) | 1990-02-13 | — | — | US | disclosed |
| US-4892884-A | ANTICHOLESTEROL, ANTILIPEMIC | RORER PHARMACEUTICAL CORPORATION (US) | 1990-01-09 | — | — | US | disclosed |